Vivo Capital as of June 30, 2018
Portfolio Holdings for Vivo Capital
Vivo Capital holds 40 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 18.6 | $144M | 2.2M | 66.52 | |
| Biohaven Pharmaceutical Holding | 10.4 | $81M | 2.0M | 39.52 | |
| Kadmon Hldgs | 8.9 | $69M | 11M | 6.59 | |
| Codexis (CDXS) | 5.7 | $44M | 3.1M | 14.40 | |
| Aclaris Therapeutics (ACRS) | 4.2 | $33M | 1.6M | 19.97 | |
| Menlo Therapeutics | 4.2 | $33M | 4.0M | 8.12 | |
| Apellis Pharmaceuticals (APLS) | 4.1 | $32M | 1.5M | 22.00 | |
| Tricida | 3.8 | $30M | 992k | 29.90 | |
| Homology Medicines | 3.7 | $29M | 1.4M | 20.40 | |
| Mei Pharma | 3.4 | $26M | 6.6M | 3.94 | |
| Arrowhead Pharmaceuticals (ARWR) | 3.3 | $26M | 1.9M | 13.60 | |
| Eiger Biopharmaceuticals | 2.8 | $22M | 1.8M | 12.20 | |
| Amyris (AMRSQ) | 2.3 | $18M | 2.8M | 6.39 | |
| Madrigal Pharmaceuticals (MDGL) | 2.2 | $17M | 62k | 279.68 | |
| Kala Pharmaceuticals | 1.9 | $14M | 1.0M | 13.73 | |
| Nabriva Therapeutics | 1.8 | $14M | 4.1M | 3.48 | |
| Obseva Sa | 1.8 | $14M | 925k | 15.14 | |
| Cymabay Therapeutics | 1.6 | $12M | 906k | 13.42 | |
| Strongbridge Bioph shs usd | 1.5 | $12M | 1.9M | 6.00 | |
| Selecta Biosciences (RNAC) | 1.3 | $10M | 781k | 13.25 | |
| Soleno Therapeutics | 1.3 | $10M | 4.4M | 2.34 | |
| Deciphera Pharmaceuticals (DCPH) | 1.3 | $10M | 253k | 39.35 | |
| Galmed Pharmaceuticals | 1.2 | $9.4M | 793k | 11.90 | |
| Zymeworks | 1.2 | $9.2M | 620k | 14.78 | |
| Sierra Oncology | 0.9 | $7.2M | 2.4M | 2.96 | |
| Genocea Biosciences | 0.9 | $7.0M | 8.2M | 0.86 | |
| Aurinia Pharmaceuticals (AUPH) | 0.9 | $6.8M | 1.2M | 5.63 | |
| Regenxbio Inc equity us cm (RGNX) | 0.8 | $5.9M | 82k | 71.74 | |
| Zai Lab (ZLAB) | 0.7 | $5.4M | 231k | 23.25 | |
| Zogenix | 0.6 | $4.6M | 105k | 44.20 | |
| Foamix Pharmaceuticals | 0.6 | $4.3M | 855k | 5.01 | |
| Biopharmx | 0.5 | $3.5M | 16M | 0.22 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.4 | $3.2M | 186k | 17.35 | |
| Verona Pharma Plc ads (VRNA) | 0.4 | $2.8M | 1.5M | 1.87 | |
| Trevena | 0.3 | $2.5M | 1.7M | 1.44 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $2.4M | 300k | 8.12 | |
| Agile Therapeutics | 0.1 | $742k | 1.5M | 0.49 | |
| Akari Therapeutics | 0.1 | $674k | 346k | 1.95 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $414k | 196k | 2.12 | |
| Soleno Therapeutics, Inc. warrant | 0.0 | $79k | 189k | 0.42 |
